1. Home
  2. BNR

BNR

Burning Rock Biotech Limited

Logo Burning Rock Biotech Limited

Health Care

Medical Specialities

Nasdaq

as 04-24-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Burning Rock Biotech Ltd is a cancer diagnostics company. Its products include OncoScreen Plus and ColonCore. The company has developed various cancer detection products, involving tumor targeting, differentiation of benign and malignant tumors, monitoring of small residual lesions, prediction of tumor recurrence progress, and detection of tumor sensitivity. It offers 12 NGS-based cancer therapy selection tests comprising a broad range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer, using both tissue and liquid biopsy samples.

Founded: 2014 Country:
China
China
Employees: N/A City: N/A
Market Cap: 73.9M IPO Year: 2020
Target Price: N/A AVG Volume (30 days): 49.9K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.88 EPS Growth: N/A
52 Week Low/High: $0.57 - $3.25 Next Earning Date: 05-28-2024
Revenue: $75,801,834 Revenue Growth: -4.58%
Revenue Growth (this year): 52.9% Revenue Growth (next year): 48.35%

Share on Social Networks: